Target Audience
This CME activity is primarily intended and designed to educate pathologists.
Educational Objectives
At the completion of this CME activity, subscribers should be able to:
– Explain the spectrum of benign spindle cell lesions in the breast.
– Describe sclerosing lesions of the breast.
– Identify key features of genomic testing in breast cancer diagnosis and treatment planning.
– Discuss breast cancer predictive factor testing (ER, PR & HER2).
– Describe the diagnostic features and clinical significance of a variety of breast lesions with particular reference to the implications of these diagnoses in core needle biopsy specimens.
Topics/Speakers:
Ductal Carcinoma In Situ of Breast: Updates and Differential Diagnoses
Charles D. Sturgis, M.D.
Spindle Cell and Vascular Lesions of Breast
Christopher D.M. Fletcher, M.D., FRCPath
Benign Breast Disease: Atypical Proliferative Lesion: Diagnosis and Breast Cancer Risk
David G. Hicks, M.D.
Sclerosing Lesions of the Breast
David G. Hicks, M.D.
Genomic in Breast Cancer Diagnosis and Treatment Planning: Is this an Opportunity to Enhance the Role of Pathologists in Multidisciplinary Care?
David G. Hicks, M.D.
Breast Cancer Predictive Factor Testing (ER, PR & HER2): Bridging the Gap Between Diagnosis and Management
David G. Hicks, M.D.
Ancillary Breast Cancer Studies: Rogue Cases, Challenges, Pitfalls and Trouble Shooting
David G. Hicks, M.D.
Challenging Breast Pathology Case Studies
David G. Hicks, M.D.
CME Release Date 1/14/2021
CME Expiration Date 1/14/2024
